Submit Deal

Announced

22 Feb 2023

Completed

22 Feb 2023

Kotak Special Situations Fund completed a INR10.7bn investment in Biocon.

Synopsis

Kotak Special Situations Fund, an alternative investment fund, completed a INR10.7bn investment in Biocon, a biopharmaceutical company. “We are delighted to partner with Biocon, and this acquisition financing supports Biocon’s journey of becoming a world-leading, fully integrated biosimilars enterprise," Eshwar Karra, Kotak Special Situations Fund CEO.

Principals

target

Biocon

bidder

Kotak Investment Advisors

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Seller Team (1)

siddharth mittal

CEO at BIOCON LIMITED

Manager

target

Deals

£ 4.98 B

Total Value

Bidder Team (5)

srini sriniwasan

Managing Director at KOTAK INVESTMENT ADVISORS LTD

Investor

bidder

Deals

£ 468 M

Total Value

mahesh nayak

Vice President Group Corporate Communication at KOTAK INVESTMENT ADVISORS LTD

Manager

bidder

Deals

£ 145 M

Total Value

prasanna deshpande

Public Relations Manager at Fortuna PR

PR Consultant

bidder

Deal

£ 107 M

Total Value

rakesh sharma

Partner at Fortuna PR

PR Consultant

bidder

Deal

£ 107 M

Total Value

eshwar karra

CEO of Kotak Special Situations Fund at KOTAK SPECIAL SITUATIONS FUND

Manager

bidder

Deals

£ 396 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy